---
title: "Genomic SEM and Mendelian Randomization Reveal Genetic Links Between Substance Use, Psychiatric Di"
id: "medrxiv-9-latent-genetic-factors-and-causal-pathways-linking-substance-use-to-psychiatric"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-9-latent-genetic-factors-and-causal-pathways-linking-substance-use-to-psychiatric"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.28.26364160v1?rss=1"
published_at: "2026-10-05T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Genomic SEM and Mendelian Randomization Reveal Genetic Links Between Substance Use, Psychiatric Di
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-9-latent-genetic-factors-and-causal-pathways-linking-substance-use-to-psychiatric
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.28.26364160v1?rss=1)
- **Published At:** 2026-10-05T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study used large European-ancestry GWAS summary statistics for six **substance use** behaviors and twelve psychiatric and personality phenotypes to investigate shared genetics and causal relationships. - Two complementary genetically informed methods were applied: **Genomic Structural Equation Modelling (Genomic SEM)** to identify latent genetic factors among psychiatric and personality traits, and **Mendelian Randomization (MR)** to test bidirectional causal effects between traits and substance use behaviors. - Genomic SEM identified a three-factor latent structure: F1 (PTSD, MDD, GAD, ADHD, agreeableness), F2 (BD, SCZ, OCD, openness), and F3 (OCD, GAD, extraversion, neuroticism). These factors showed distinct genetic correlations with substance use traits. - Smoking-related phenotypes showed significant genetic correlations with all three latent factors, strongest with F1. Alcohol use had weak but significant correlations with F1 and F2. Cannabis use correlated moderately with F1 and F2, strongest with F2. - MR analyses produced several robust causal signals: smoking continuation was causally associated with increased bipolar disorder risk; cigarettes per day with increased schizophrenia risk; smoking initiation with increased extraversion and decreased agreeableness. - Genetic liability to schizophrenia and PTSD was causally associated with higher risk of cannabis ever use; schizophrenia liability was also causally linked to increased alcohol use. - Personality liabilities (neuroticism, openness, agreeableness) showed causal links to smoking behaviors, and extraversion to cannabis use. - Many tested relationships yielded weak causal evidence or were affected by heterogeneity and pleiotropy, limiting causal inference for several associations. - All analyses used previously published GWAS summary statistics; data sources and links are provided in the manuscript. The work is a preprint and has not been peer reviewed, and the authors declared no competing interests. - Findings support both **shared genetic liability** and a subset of **direct causal effects** between substance use behaviors, psychiatric disorders, and personality traits, with implications for future prevention and intervention research.
## Clinical Analysis & Structured Key Points
Latent Genetic Factors and Causal Pathways Linking Substance Use to Psychiatric and Personality Phenotypes: a Genomic SEM and Mendelian Randomization Study | medRxiv Skip to main content Latent Genetic Factors and Causal Pathways Linking Substance Use to Psychiatric and Personality Phenotypes: a Genomic SEM and Mendelian Randomization Study View ORCID Profile Kaya C. van Grondelle , View ORCID Profile Adria Tunez , View ORCID Profile Joelle A. Pasman , View ORCID Profile Merel Wouda , View ORCID Profile Laura W. Wesseldijk , View ORCID Profile Bochao D. Lin , View ORCID Profile Anastasia A. Goula , View ORCID Profile Karin J.H. Verweij , View ORCID Profile Jurjen J. Luykx doi: https://doi.org/10.64898/2026.09.28.26364160 Kaya C. van Grondelle 1 Amsterdam UMC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Kaya C. van Grondelle For correspondence: kayavg{at}gmail.com Adria Tunez 1 Amsterdam UMC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Adria Tunez Joelle A. Pasman 2 Amsterdam UMC location University of Amsterdam; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Joelle A. Pasman Merel Wouda 1 Amsterdam UMC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Merel Wouda Laura W. Wesseldijk 1 Amsterdam UMC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Laura W. Wesseldijk Bochao D. Lin 3 Maastricht University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Bochao D. Lin Anastasia A. Goula 4 Amsterdam University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Anastasia A. Goula Karin J.H. Verweij 5 Amsterdam UMC - Locatie AMC: Amsterdam UMC Locatie AMC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Karin J.H. Verweij Jurjen J. Luykx 6 UMCU Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jurjen J. Luykx Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Substance use and psychiatric disorders frequently co-occur, but establishing causality of their relationships is difficult given the multifactorial nature of these traits. To assess these relationships, we applied two genetically informed methods using the largest available European-ancestry genome-wide association studies of six substance use behaviors and twelve psychiatric and personality phenotypes. Using Genomic Structural Equation Modelling, we modelled the latent genetic architecture of the psychiatric and personality traits and examined these factors' correlations with substance use traits. A structure with three factors fit the data best: F1 (PTSD, MDD, GAD, ADHD, agreeableness), F2 (BD, SCZ, OCD, openness), and F3 (OCD, GAD, extraversion, neuroticism), which showed differential correlations with substance use. Smoking correlated significantly which each factor, however, strongest with F1, alcohol use showed weak but significant correlations with F1 and F2, and cannabis use showed moderate correlations with F1 and F2, but strongest with F2. Using Mendelian Randomization, we examined bidirectional causal relationships. We found strong evidence that smoking continuation was causally associated with increased bipolar disorder risk, cigarettes per day with increased schizophrenia, and smoking initiation with increased extraversion and decreased agreeableness. Genetic liability to schizophrenia and PTSD were causally associated with increased risk of cannabis use, and schizophrenia with increased alcohol use. Liability to neuroticism, openness and agreeableness was causally linked to smoking behaviors, and extraversion to cannabis use. Most remaining associations showed weak causal evidence, largely due to heterogeneity and pleiotropy. Together, these findings provide evidence for both shared genetic liability and, for a subset of relationships, direct causal effects between substance use behaviors, psychiatric disorders, and personality traits, which can help inform future intervention and prevention research. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: All GWAS summary statistics analysed in this study are from previously published studies. Summary statistics are available at the following locations: Age of smoking initiation, cigarettes per day, drinks per week, smoking cessation, and smoking initiation (Saunders et al., 2022): https://conservancy.umn.edu/items/91f6a003-6af2-4809-9785-53dc579dc788 Cannabis ever use (Pasman et al., 2018): https://www.ru.nl/bsi/research/group-pages-0/substance-use-addiction-food-saf/vm-saf/genetics/international-cannabis-consortium-icc/ Agreeableness, extraversion, neuroticism, conscientiousness and openness (Schwaba et al., 2026): https://doi.org/10.17605/OSF.IO/HGNSM ADHD (van der Laan et al., 2025): https://www.ebi.ac.uk/gwas/studies/GCST90568441 Bipolar disorder (O'Connell et al., 2025): https://figshare.com/ndownloader/files/49760772 Generalized anxiety symptoms (Skelton et al., 2026): https://figshare.com/ndownloader/files/62613733 Major depressive disorder (Adams et al., 2025): https://figshare.com/ndownloader/files/51487019 Obsessive-compulsive disorder (Strom et al., 2025): https://figshare.com/ndownloader/files/53357735 Post-traumatic stress disorder (Nievergelt et al., 2024): https://figshare.com/ndownloader/files/47850151 Schizophrenia (Trubetskoy et al., 2022): https://figshare.com/ndownloader/files/34517828 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All GWAS summary statistics analysed in this study are from previously published studies and are available online from the sources listed in the Data Availability Links section. All results generated in this study are contained in the manuscript and its Supplementary Materials. Funder Information Declared Dutch Research Council, https://ror.org/04jsz6e67 , 406.22.GO.043 Amsterdam University Medical Center Postdoc Career Bridging , 27527 Volksbond Rotterdam Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted October 05, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Latent Genetic Factors and Causal Pathways Linking Substance Use to Psychiatric and Personality Phenotypes: a Genomic SEM and Mendelian Randomization Study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Latent Genetic Factors and Causal Pathways Linking Substance Use to Psychiatric and Personality Phenotypes: a Genomic SEM and Mendelian Randomization Study Kaya C. van Grondelle , Adria Tunez , Joelle A. Pasman , Merel Wouda , Laura W. Wesseldijk , Bochao D. Lin , Anastasia A. Goula , Karin J.H. Verweij , Jurjen J. Luykx medRxiv 2026.09.28.26364160; doi: https://doi.org/10.64898/2026.09.28.26364160 Share This Article: Copy Citation Tools Latent Genetic Factors and Causal Pathways Linking Substance Use to Psychiatric and Personality Phenotypes: a Genomic SEM and Mendelian Randomization Study Kaya C. van Grondelle , Adria Tunez , Joelle A. Pasman , Merel Wouda , Laura W. Wesseldijk , Bochao D. Lin , Anastasia A. Goula , Karin J.H. Verweij , Jurjen J. Luykx medRxiv 2026.09.28.26364160; doi: https://doi.org/10.64898/2026.09.28.26364160 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (625) Allergy and Immunology (913) Anesthesia (340) Cardiovascular Medicine (4883) Dentistry and Oral Medicine (484) Dermatology (421) Emergency Medicine (658) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1641) Epidemiology (16056) Forensic Medicine (34) Gastroenterology (1218) Genetic and Genomic Medicine (7123) Geriatric Medicine (736) Health Economics (1072) Health Informatics (5117) Health Policy (1447) Health Systems and Quality Improvement (1792) Hematology (589) HIV/AIDS (1355) Infectious Diseases (except HIV/AIDS) (16352) Intensive Care and Critical Care Medicine (1183) Medical Education (677) Medical Ethics (156) Nephrology (729) Neurology (7377) Nursing (370) Nutrition (1101) Obstetrics and Gynecology (1261) Occupational and Environmental Health (1010) Oncology (3655) Ophthalmology (1066) Orthopedics (399) Otolaryngology (459) Pain Medicine (483) Palliative Medicine (142) Pathology (711) Pediatrics (1821) Pharmacology and Therapeutics (741) Primary Care Research (775) Psychiatry and Clinical Psychology (5979) Public and Global Health (9829) Radiology and Imaging (2461) Rehabilitation Medicine and Physical Therapy (1478) Respiratory Medicine (1256) Rheumatology (648) Sexual and Reproductive Health (785) Sports Medicine (588) Surgery (786) Toxicology (107) Transplantation (310) Urology (297)
## Related Clinical Research

- [State-level links between gender-based violence and mental health burden in India, 2001–2021](https://medichelpline.com/clinical-feed/medrxiv-9-gender-based-violence-rates-and-mental-health-disease-burden-in-india-2001-2021.md)
- [Prevalence, Severity and Predictors of Antipsychotic-Related Adverse Drug Reactions in a Ugandan R](https://medichelpline.com/clinical-feed/plos-one-14-prevalence-severity-and-predictors-of-antipsychotic-related-adverse-drug.md)
- [Quetiapine in Pregnancy: Reproductive Safety, Malformation Rates, and Metabolic Risks](https://medichelpline.com/clinical-feed/womens-mental-health-0-quetiapine-use-during-pregnancy-what-do-we-know-about-reproductive-safety.md)
- [Heterogeneity in Excess Mortality by Diagnosis, Care Setting, and Substance Use in Finland Cohort](https://medichelpline.com/clinical-feed/medrxiv-17-heterogeneity-in-excess-mortality-across-mental-behavioural-and.md)
- [Lithium in Pregnancy: Risks of Preterm Birth, LGA, and Cardiac Malformations](https://medichelpline.com/clinical-feed/womens-mental-health-0-lithium-use-in-pregnancy-and-the-risk-of-adverse-perinatal-outcomes.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.